622 filings
Page 20 of 32
4
NBSE
NeuBase Therapeutics Inc
8 Dec 15
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
3 Dec 15
Ohr Pharmaceutical Announces Positive Preclinical Data in SKS Sustained Release Ocular Program
12:00am
4
NBSE
NeuBase Therapeutics Inc
24 Nov 15
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
17 Nov 15
Ohr Pharmaceutical Presents New Data from OHR-102 Phase II IMPACT Study in Wet-AMD at American Academy of Ophthalmology Annual Meeting
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
12 Nov 15
Ohr Pharmaceutical Announces Submission of a Special Protocol Assessment and Upcoming Presentation on OHR-102 at American Academy of Ophthalmology
12:00am
4
NBSE
NeuBase Therapeutics Inc
4 Nov 15
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
10 Aug 15
Departure of Directors or Certain Officers
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
7 Aug 15
Ohr Pharmaceutical Reports Fiscal Third Quarter 2015 Financial and Business Results
12:00am
10-Q
2015 Q3
NBSE
NeuBase Therapeutics Inc
Quarterly report
6 Aug 15
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
15 Jul 15
Ohr Pharmaceutical Announces Positive Results of a Phase II Clinical Study for OHR-102 in Retinal Vein Occlusion
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
11 Jun 15
Letter from SEC
12:00am
CORRESP
NBSE
NeuBase Therapeutics Inc
18 May 15
Correspondence with SEC
12:00am
10-Q
2015 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
11 May 15
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
8 May 15
Ohr Pharmaceutical Presents Data From OHR-102 Phase II IMPACT Study in Wet-AMD at ARVO Conference
12:00am
CORRESP
NBSE
NeuBase Therapeutics Inc
6 May 15
Correspondence with SEC
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
22 Apr 15
Letter from SEC
12:00am
SC 13G
NBSE
NeuBase Therapeutics Inc
7 Apr 15
Ohr Pharmaceutical Inc
12:00am
CORRESP
NBSE
NeuBase Therapeutics Inc
2 Apr 15
Correspondence with SEC
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
30 Mar 15
Ohr Pharmaceutical Announces Final Topline Data From OHR-102 Phase II IMPACT Study in Wet-AMD
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
18 Mar 15
Letter from SEC
12:00am